Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart shirt could monitor your heart and lungs without wires

NCT ID NCT05473702

Knowledge-focused Sponsor: Nanowear Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a wearable smart textile sensor system called SimpleSense in 334 people. The device uses special sensors in a harness to record heart signals, breathing, and body movement. Researchers compared its readings to standard hospital monitors to see if it works just as well. The goal is to provide a comfortable, wireless way to keep track of heart and lung health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nanowear SimpleSense wearable monitoring device
What this could lead to
If successful, this could lead to a comfortable, wearable way to continuously monitor heart and lung health at home.
What could go wrong
This is a completed study focused on accuracy, not treatment. The device may not work as well in real-world settings or for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

334 people

The number who actually took part.

Started

Oct 2014

Finished

Mar 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

200 willing subjects evenly spread across age range, gender, BMI.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy subject with no pre-existing conditions. * Subject with prehypertension * Subject with hypertension * Subject undergoing dialysis Exclusion Criteria: * Pregnant women * Subjects with implantable cardiac devices (for example, pacemaker or internal cardioverter defibrillator). * Subjects with arrhythmia.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blood pressure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cardiac rhythm disease chronic obstructive pulmonary disease COPD, severe early onset heart disorder hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Blood pressure Heart disease chronic Heart rhythm disorder Pulmonary disease, chronic obstructive

Contacts and locations

Locations

  • Clincept

    Atlanta, Georgia, 31904, United States

  • Maimonides Medical Center

    Brooklyn, New York, 11219, United States

  • Nanowear R&D

    State College, Pennsylvania, 16803, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.